Citadel Advisors’s Imunon IMNN Stock Holding History

Citadel Advisors’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-983	Closed	-$12.2K	–	14992
2024 Q4	$12.2K	Sell	983 -1,623	-62%	-$18.8K	﹤0.01%	13509
2024 Q3	$36K	Buy	+2,606	New	+$41.3K	﹤0.01%	12263
2024 Q1	–	Sell	-2,271	Closed	-$20.1K	–	14992
2023 Q4	$20.1K	Sell	2,271 -1,169	-34%	-$14.3K	﹤0.01%	12611
2023 Q3	$43.5K	Sell	3,440 -522	-13%	-$8.15K	﹤0.01%	11912
2023 Q2	$66.7K	Sell	3,962 -933	-19%	-$15.4K	﹤0.01%	11460
2023 Q1	$79.8K	Buy	+4,895	New	+$94.1K	﹤0.01%	11560
2022 Q4	–	Sell	-2,457	Closed	-$54K	–	15150
2022 Q3	$54K	Buy	+2,457	New	+$69K	﹤0.01%	11568
2022 Q2	–	Sell	-2,522	Closed	-$166K	–	13449
2022 Q1	$166K	Buy	2,522 +2,348	+1,349%	+$184K	﹤0.01%	11741
2021 Q4	$18K	Sell	174 -73	-30%	-$11.4K	﹤0.01%	13597
2021 Q3	$45K	Sell	247 -115	-32%	-$23.9K	﹤0.01%	13420
2021 Q2	$90K	Buy	362 +238	+192%	+$56.3K	﹤0.01%	12995
2021 Q1	$33K	Buy	+124	New	+$41.7K	﹤0.01%	13014
2020 Q4	–	Sell	-691	Closed	-$82.8K	–	11201
2020 Q3	$99K	Buy	691 +564	+444%	+$142K	﹤0.01%	9281
2020 Q2	$92K	Buy	+127	New	+$55.1K	﹤0.01%	9034
2020 Q1	–	Sell	-64	Closed	-$21K	–	9861
2019 Q4	$21K	Sell	64 -103	-62%	-$31.3K	﹤0.01%	8931
2019 Q3	$50K	Sell	167 -26	-13%	-$8.9K	﹤0.01%	8702
2019 Q2	$69K	Sell	193 -93	-33%	-$37.9K	﹤0.01%	8642
2019 Q1	$110K	Buy	286 +33	+13%	+$13.7K	﹤0.01%	8513
2018 Q4	$70K	Buy	253 +189	+295%	+$78.4K	﹤0.01%	8394
2018 Q3	$35K	Buy	+64	New	+$35.3K	﹤0.01%	8888
2018 Q2	–	Sell	-100	Closed	-$49.6K	–	9031
2018 Q1	$44K	Buy	+100	New	+$48.1K	﹤0.01%	7964
2017 Q4	–	Sell	-60	Closed	-$17K	–	8194
2017 Q3	$17K	Buy	+60	New	+$18.5K	﹤0.01%	7384
2017 Q1	–	Sell	-25	Closed	-$21.5K	–	7728
2016 Q4	$21K	Buy	+25	New	+$57.1K	﹤0.01%	7072
2016 Q3	–	Sell	-4	Closed	-$13.7K	–	7450
2016 Q2	$14K	Buy	+4	New	+$15.7K	﹤0.01%	6695
2016 Q1	–	Sell	-9	Closed	-$48K	–	7316
2015 Q4	$48K	Buy	+9	New	+$46.2K	﹤0.01%	7346
2015 Q3	–	Hold	0	–	–	–	8777
2015 Q2	–	Hold	0	–	–	–	8883
2015 Q1	–	Sell	-1	Closed	-$6.96K	–	8670
2014 Q4	$4K	Sell	1 -1	-50%	-$6.94K	﹤0.01%	8302
2014 Q3	$15K	Sell	2 -1	-33%	-$8.71K	﹤0.01%	7612
2014 Q2	$25K	Sell	3 -4	-57%	-$35.7K	﹤0.01%	7185
2014 Q1	$69K	Sell	7 -1	-13%	-$10.4K	﹤0.01%	6502
2013 Q4	$90K	Buy	8 +7	+700%	+$83.9K	﹤0.01%	5690
2013 Q3	$9K	Hold	1	–	–	﹤0.01%	6486
2013 Q2	$12K	Buy	+1	New	+$13.9K	﹤0.01%	6193

Other funds holding IMNN

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VHAM

Van Hulzen Asset Management El Dorado Hills, California $1.35B AUM 22.73% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors's IMNN Position: Q1 2025 in Review

Citadel Advisors sold out of Imunon (IMNN) in Q1 2025, closing a stake of 983 shares — an estimated $12.2K sold.

Citadel Advisors first reported a position in IMNN in Q2 2013 and held it in 32 quarters. The position peaked at $166K in Q1 2022. 16 funds tracked by Wall St. Rank hold IMNN as of Q1 2025.

Citadel Advisors reported no remaining Imunon position as of Q1 2025 after selling out during the quarter.
Citadel Advisors sold 983 Imunon shares in Q1 2025, an estimated $12.2K.
Citadel Advisors first reported a position in Imunon in Q2 2013 and held it in 32 quarters.
Citadel Advisors's Imunon position peaked at $166K in Q1 2022.
16 funds tracked by Wall St. Rank held Imunon as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.